Lumida
/ARDT
⌘K
Ardent Health Inc

Ardent Health Inc

ARDT
$10.98USD+0.73%+0.08 today

MARKET CAP

1.5B

P/E (TTM)

11.6x

FWD P/E

DAY RANGE

$11 – $11

52W RANGE

$8
$15

AI Summary

Stalk
StalkMedium

ARDT broke above its June consolidation but has since drifted sideways near its short-term EMAs without decisive follow-through. The 9, 20, and 50 EMAs are flat to slightly rising, holding price support, while RSI and Options Score remain neutral, signaling no exhaustion. Medium-term bias stays bullish within a Stage 3 regime, but timing is unfavorable until renewed momentum emerges. A pullback to the 10.8–10.9 EMA zone offers a more defined engagement area. The long-term 200-day SMA is still declining, underscoring structural risk.

  • Operating cash flow surged 68% YoY to $197M in Q2 2026.
  • Repurchased $13M of stock in Q2 with $34M authorization remaining.
  • Q2 surgeries declined 2.9%, highlighting demand volatility.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2024FY 2025TREND
Sales, Adj.$6.0B$6.3B
YoY %+6.0%
P / Sales0.4x0.2x
EV / Sales0.9x0.7x
Gross Profit, Adj.$6.0B$6.3B
YoY %+6.0%
Margin %100.0%100.0%
EV / Gross Profit0.9x0.7x
EBITDA, Adj.$552.0M$481.3M
YoY %-12.8%
Margin %9.3%7.6%
EV / EBITDA9.3x8.6x
EBIT$405.8M$325.6M
YoY %-19.8%
Margin %6.8%5.1%
EV / EBIT12.7x12.7x
Net Income$210.3M$135.8M
YoY %-35.4%
Net Margin3.5%2.1%
EPS (GAAP)$1.58$0.96
YoY %-39.2%